| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/06/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 4,000 options to buy
@ $0 |
|
| 08/25/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options to buy
@ $0 |
|
| 08/25/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 options to buy
@ $0 |
|
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
4
| Sensenig Bethany (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 24,153 options to buy
@ $30.22, valued at
$729.9k
|
|
| 08/21/2023 |
3
| Sensenig Bethany (Director) has filed a Form 3 on SUPERNUS PHARMACEUTICALS, INC. |
| 08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/10/2023 |
8-K/A
| Quarterly results |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 709 shares
@ $36.47, valued at
$25.9k
Exercised 1,500 options to buy
@ $0 |
|
| 05/12/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 15,005 shares
@ $36.47, valued at
$547.2k
Exercised 31,250 options to buy
@ $0 |
|
| 05/12/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Exercised 750 options to buy
@ $0 |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/08/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 31,250 options to buy
@ $0 |
|
| 05/08/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 1,500 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 options to buy
@ $0 |
|
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/03/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even... |
| 03/16/2023 |
4
| Mottola Frank (Sr VP, Quality, GMP Oper. & IT) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 4,780 shares
@ $35.988, valued at
$172k
|
|
| 03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/02/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/27/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Rubin Jonathan (SVP, Chief Medical Officer) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $38.6, valued at
$1.5M
Granted 10,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
|